ENTITY

Adaptimmune Therapeutics (ADAP US)

5
Analysis
Health Care • United States
Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The Company develops novel cancer immunotherapy products based on T-cell receptor platform that helps to identify cancer targets. Adaptimmune Therapeutics serves customers worldwide.
more
Company Event • 25 Dec 2025 05:30 • Upcoming
Add To Calendar
Company Event • 24 Mar 2026 15:00 • Upcoming
Add To Calendar
Company Event • 13 Aug 2025 19:30 • Upcoming
Add To Calendar
Company Event • 13 May 2025 20:00 • Latest
Company Event • 20 Mar 2025 20:00
x